STAT February 10, 2025
Brittany Trang

Experts are skeptical of the grand claims of startups like Absci and Generate Biomedicines

It was January 2023. Elon Musk owned Twitter, but it wasn’t yet called X. ChatGPT had been released barely six weeks earlier.

Absci CEO Sean McClain — tall, with short, gelled hair and a beard, the kind of all-American entrepreneur who mowed lawns to buy...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma / Biotech, Technology
5 Key AI Players Leading the Drug Discovery Push
Physicians hop on the GLP-1 train
Navigating Challenges in Drug-Device Combinations under EU MDR Article 117
Pharma Pulse 2/10/25: How 2025 Will Reshape Patient Support, ‘Food is Medicine’ & more
Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma

Share This Article